Maverick Capital’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
Maverick Capital's AMAG Position: Q4 2020 in Review
Maverick Capital sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 115,895 shares — an estimated $1.09M sold.
Maverick Capital first reported a position in AMAG in Q2 2020 and held it in 2 quarters. The position peaked at $1.28M in Q2 2020. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Maverick Capital reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Maverick Capital sold 115,895 AMAG Pharmaceuticals shares in Q4 2020, an estimated $1.09M.
- Maverick Capital first reported a position in AMAG Pharmaceuticals in Q2 2020 and held it in 2 quarters.
- Maverick Capital's AMAG Pharmaceuticals position peaked at $1.28M in Q2 2020.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Maverick Capital's 13F filing for Q4 2020, filed 16 Feb 2021.